This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bentrem, D. Articles by Coit, D. Search for Related Content PubMed PubMed Citation Articles by Bentrem, D. Articles by Coit, D.

The Value of Peritoneal Cytology as a Preoperative Predictor in Patients With Gastric Carcinoma Undergoing a Curative Resection

¹ Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10021
² Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10021

Correspondence: Address correspondence and reprint requests to: Daniel Coit, MD; E-mail: coitd{at}mskcc.org.

Background: Although positive peritoneal cytology is associated with poor prognosis, it has not been found to be independently predictive of outcome when evaluated in context of post-resection pathologic T and N stage. This study was undertaken to evaluate the predictive value of positive cytology in context of other prognostic factors available prior to surgery in patients undergoing R0 resection for gastric cancer, to assess its role in selecting patients for appropriate treatment prior to surgical resection.

Methods: Clinical variables for all patients undergoing R0 resection for gastric adenocarcinoma at Memorial Sloan-Kettering Cancer Center from 1993–2002 were reviewed from a prospective database. Patients underwent preoperative assessment of T and N stage with CT scan, laparoscopy, and endoscopic and/or laparoscopic ultrasound. Peritoneal cytology was obtained in all patients.

Results: Patients with gastric cancer (n = 371) underwent R0 resection and staging laparoscopy with peritoneal washings; 24 patients (6.5%) had positive peritoneal cytology. Positive cytology was associated with advanced T stage (P = 0.02) but not with nodal positivity (P = 0.11). Median survival of patients with positive cytology was 14.8 months vs. 98.5 months for patients with negative cytology (P < 0.001). Multivariate analysis identified preoperative T stage, preoperative N stage, site, and cytology as significant predictors of outcome. Positive cytology was the preoperative factor most predictive of death from gastric cancer (RR 2.7, P < 0.001).

Conclusions: Positive cytology is information potentially available preoperatively that identifies a patient population at very high risk for early recurrence and death after curative resection of gastric cancer.

Key Words: Cytology • Stomach neoplasm • Staging • Metastasis • Peritoneal lavage

This article has been cited by other articles:

				B. Badgwell, J. N. Cormier, S. Krishnan, J. Yao, G. A. Staerkel, P. J. Lupo, P. W. T. Pisters, B. Feig, and P. Mansfield Does Neoadjuvant Treatment for Gastric Cancer Patients with Positive Peritoneal Cytology at Staging Laparoscopy Improve Survival? Ann. Surg. Oncol., October 1, 2008; 15(10): 2684 - 2691. [Abstract] [Full Text] [PDF]

				S. Rekhraj, O. Aziz, S. Prabhudesai, E. Zacharakis, F. Mohr, T. Athanasiou, A. Darzi, and P. Ziprin Can intra-operative intraperitoneal free cancer cell detection techniques identify patients at higher recurrence risk following curative colorectal cancer resection: a meta-analysis Ann. Surg. Oncol., January 1, 2008; 15(1): 60 - 68. [Abstract] [Full Text] [PDF]

				J. S. Gold, D. P. Jaques, D. J. Bentrem, M. A. Shah, L. H. Tang, M. F. Brennan, and D. G. Coit Outcome of Patients with Known Metastatic Gastric Cancer Undergoing Resection with Therapeutic Intent Ann. Surg. Oncol., February 1, 2007; 14(2): 365 - 372. [Abstract] [Full Text] [PDF]